IL155174A0 - Methods and compositions for the treatment of inflammatory diseases - Google Patents

Methods and compositions for the treatment of inflammatory diseases

Info

Publication number
IL155174A0
IL155174A0 IL15517401A IL15517401A IL155174A0 IL 155174 A0 IL155174 A0 IL 155174A0 IL 15517401 A IL15517401 A IL 15517401A IL 15517401 A IL15517401 A IL 15517401A IL 155174 A0 IL155174 A0 IL 155174A0
Authority
IL
Israel
Prior art keywords
compositions
treatment
methods
inflammatory diseases
inflammatory
Prior art date
Application number
IL15517401A
Other languages
English (en)
Original Assignee
Reddy Us Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Reddy Us Therapeutics Inc filed Critical Reddy Us Therapeutics Inc
Publication of IL155174A0 publication Critical patent/IL155174A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/48—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
    • C12Q1/485—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase involving kinase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6897—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids involving reporter genes operably linked to promoters
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/91—Transferases (2.)
    • G01N2333/912—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • G01N2333/91205—Phosphotransferases in general
    • G01N2333/9121—Phosphotransferases in general with an alcohol group as acceptor (2.7.1), e.g. general tyrosine, serine or threonine kinases
    • G01N2333/91215—Phosphotransferases in general with an alcohol group as acceptor (2.7.1), e.g. general tyrosine, serine or threonine kinases with a definite EC number (2.7.1.-)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL15517401A 2000-10-02 2001-10-02 Methods and compositions for the treatment of inflammatory diseases IL155174A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US23714700P 2000-10-02 2000-10-02
PCT/US2001/042428 WO2002029091A2 (en) 2000-10-02 2001-10-02 Methods and compositions for the treatment of inflammatory diseases

Publications (1)

Publication Number Publication Date
IL155174A0 true IL155174A0 (en) 2003-10-31

Family

ID=22892514

Family Applications (1)

Application Number Title Priority Date Filing Date
IL15517401A IL155174A0 (en) 2000-10-02 2001-10-02 Methods and compositions for the treatment of inflammatory diseases

Country Status (10)

Country Link
US (1) US6900041B2 (pl)
EP (1) EP1334207A2 (pl)
AU (1) AU2001296959A1 (pl)
BR (1) BR0114411A (pl)
CA (1) CA2424246A1 (pl)
EA (1) EA200300442A1 (pl)
IL (1) IL155174A0 (pl)
MX (1) MXPA03002916A (pl)
PL (1) PL366009A1 (pl)
WO (1) WO2002029091A2 (pl)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL156651A0 (en) * 2000-12-29 2004-01-04 Reddy Us Therapeutics Inc Detection of compounds that modulate inflammatory responses
US7363569B2 (en) 2001-06-29 2008-04-22 Intel Corporation Correcting for data losses with feedback and response
US7231653B2 (en) 2001-09-24 2007-06-12 Intel Corporation Method for delivering transport stream data
AU2003210769A1 (en) * 2002-01-31 2003-09-02 Reddy Us Therapeutics, Inc. Methods and compositions for identification and therapeutic use of genes involved in vascular and proliferative diseases
WO2004016229A2 (en) * 2002-08-16 2004-02-26 Wyeth Compositions and methods for treating rage-associated disorders
CN1993378A (zh) * 2004-08-03 2007-07-04 转化技术制药公司 Rage融合蛋白及使用方法
AP2007003893A0 (en) * 2004-08-03 2007-02-28 Transtech Pharma Inc Rage fusion proteins and methods of use
EP1749523A1 (en) * 2005-07-29 2007-02-07 Neuropharma, S.A. GSK-3 inhibitors
WO2007073272A1 (en) * 2005-12-23 2007-06-28 Gcoder Systems Ab Positioning pattern
CN101410411A (zh) * 2006-02-09 2009-04-15 转化技术制药公司 Rage融合蛋白及使用方法
BRPI0711193A2 (pt) 2006-05-05 2013-06-18 Transtech Pharma Inc proteÍnas de fusço rage, formulaÇÕes e mÉtodos de uso dos mesmos
US20080199467A1 (en) * 2007-02-15 2008-08-21 Mjalli Adnan M M Immunoglobulin fusion proteins and methods of making
EP2158210B1 (en) * 2007-06-14 2015-12-09 Galactica Pharmaceuticals, Inc. Rage fusion proteins
CN102803292A (zh) 2009-04-20 2012-11-28 辉瑞公司 蛋白质糖基化的控制及其相关组合物和方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5807884A (en) * 1992-10-30 1998-09-15 Emory University Treatment for atherosclerosis and other cardiovascular and inflammatory diseases
GB9828640D0 (en) * 1998-12-23 1999-02-17 Smithkline Beecham Plc Novel method and compounds
EP1244461A2 (en) * 1999-12-23 2002-10-02 The Ontario Cancer Institute INHIBITION OF GSK-3$g(b)
IL153851A0 (en) * 2000-07-27 2003-07-31 Hoffmann La Roche 3-indolyl-4-phenyl-1h-pyrrole-2,5-dione derivatives as inhibitors of glycogen synthase kinase-3beta
IL156651A0 (en) * 2000-12-29 2004-01-04 Reddy Us Therapeutics Inc Detection of compounds that modulate inflammatory responses

Also Published As

Publication number Publication date
WO2002029091A2 (en) 2002-04-11
EA200300442A1 (ru) 2003-10-30
US20020077293A1 (en) 2002-06-20
BR0114411A (pt) 2006-05-09
AU2001296959A1 (en) 2002-04-15
EP1334207A2 (en) 2003-08-13
WO2002029091A3 (en) 2003-05-30
US6900041B2 (en) 2005-05-31
MXPA03002916A (es) 2004-12-03
PL366009A1 (pl) 2005-01-24
CA2424246A1 (en) 2002-04-11

Similar Documents

Publication Publication Date Title
IL155092A0 (en) Compounds useful in the treatment of inflammatory diseases
PL362711A1 (pl) Pochodne morfolinoacetamidu do leczenia chorób zapalnych
AU6147401A (en) Compositions and methods for the treatment of cancer
PL348059A1 (en) Compounds useful in the treatment of inflammatory diseases
WO2003034984A9 (en) Compositions and methods for the diagnosis and treatment of inflammatory bowel disorders
AU2002352726A8 (en) Formulations and methods for treatment or amelioration of inflammatory conditions
AU6118001A (en) Combination therapeutic compositions and methods of use
AU2001259758A1 (en) Interleukin-1 inhibitors in the treatment of diseases
ZA200301204B (en) Compositions and methods for the diagnosis and treatment of tumor
AU2002233928A1 (en) Cycloalkylfused (g)-indole compounds as spla2-inhibitors in the treatment of inflammatory diseases
AU3840802A (en) Methods and compositions for the treatment of diseases of the eye
PL366009A1 (pl) Sposoby i kompozycje do leczenia chorób zapalnych
AU3632600A (en) Compositions and methods for the treatment of immune related diseases
PL371281A1 (pl) Sposoby i kompozycje do leczenia chorób oczu
AU8678501A (en) Compositions and methods for the diagnosis and treatment of tumor
EP1416795A4 (en) COMPOSITIONS AND METHODS OF TREATING DISEASES OF MITOCHONDRIA
PL368035A1 (pl) Kompozycje i sposoby leczenia raka
AU2001267404A1 (en) Novel compounds for the treatment of inflammatory and cardiovascular diseases
EP1472273A4 (en) COMPOSITIONS AND METHODS FOR THE TREATMENT OF IMMUNE DISEASES
AU1953701A (en) Methods and compositions for treatment of inflammatory disease
IL155769A0 (en) Method for the treatment of inflammation
AU3434601A (en) Compositions and methods for the treatment of immune related diseases
AU4515001A (en) Compositions and methods for locally treating inflammatory diseases
IL141551A0 (en) Compositions and methods for the treatment of immune related diseases
EP1315499A4 (en) COMPOSITIONS AND METHODS OF TREATING ANORCAL DISEASES